Workers.org

Support
anti-war,
anti-racist
news

:: Donate now ::


Email this articleEmail this article 

Print this pagePrintable page


Email the editor

 

SOUTH AFRICA

Victory over U.S. drug giants, but struggle continues

By Key Martin

Southern Africa is the cauldron in which the battle against the AIDS epidemic is being forged and where the fate of humanity in the face of this scourge may well be decided. It was late afternoon on Sept. 17 in Washington when U.S. Trade Representative Charlene Barshefsky announced the U.S. concession to "support" South Africa's efforts to obtain cheaper medicines to help combat the exploding AIDS epidemic in the region.

This concession saved Washington the embarrassment of confronting newly elected President Thabo Mbeki during his mid-September appearances at the United Nations. Protests, however, are expected to continue.

U.S. actions against South Africa blocked medical treatment while the death toll mushroomed in the entire subcontinent. It took months of protests by Act Up and the Health Gap Coalition and others--in both the United States and South Africa--to defeat the pharmaceutical companies and Vice President Al Gore. Gore represented the Clinton administration in threatening South Africa on these matters.

The drug companies took legal action in the South African Constitutional Court. Washington started trade sanctions against some South African products. Their goal was to stop South Africa from implementing a new law that would lower drug prices.

The South Africans face a devastatingly high rate of HIV infection and the legacy of an apartheid-era health-care system that left the poor largely without treatment.

The concession "temporarily" halted the legal action without dropping it completely. The U.S. government withdrew sanctions and agreed to take South Africa off the "watch list." This is a list of countries against which some economic sanctions would be considered when the list is redone later in the fall.

"We've acknowledged each other's policy decisions and the South African government made it quite clear that it was never our intention to infringe on the intellectual property rights of any person or any company," said Minister of Trade and Industry Alec Irwin during President Mbeki's New York visit.

"What was at stake was the so-called parallel import issue. The U.S. government, on behalf of the companies, took this matter up very forcefully. So did the German government, the United Kingdom, Switzerland. We had discussions with all those governments and reached an understanding.

"We have not attempted to reach agreement on `exhaustion.' That is a multi-national issue that will come up in the World Trade Organization."

"Exhaustion" refers to the fact that a patent holder loses the right to the patented product once it is sold. It can then be resold without infringing on patent rights. "Parallel importing" is the right to buy medicines at the cheapest price from any source, not just from the drug monopolies at their fixed prices.

"There is a separate issue that has also emerged within the World Health Organization, and that is the affordability of crucial drugs--not only AIDS drugs, but a range of drugs, from malaria to tuberculosis. I think the WHO may be a much better place to discuss this than the International Monetary Fund--which has nothing to do with drugs and should stay out of it. It's crucial for Africa," Irwin said.

Special Assistant to the Minister of Health Ian Roberts helped write the new law in question. "When the ANC government took power in South Africa and started the process of transformation," said Roberts, "one of the earliest things the government addressed was altering the legislation from an apartheid-based structure to a democratic structure. And that meant that we changed about 100 acts a year.

"One of the very crucial areas dealt with medicines and the medical market place. We designed an act to address all the critical transformation issues that surround medicines. The act covered basically five main topics: rational prescribing, altering the ethical base of the marketplace, affordability of medicines, strengthening the regulatory process, and control of the effects of medicines," he said.

While the pharmaceuticals focused their publicity on the question of intellectual property, Roberts explained, in fact they attacked the law in its entirety.

"That is one reason why the government is so resolute in defending the act. For instance, generic substitution is illegal in South Africa. An enormous market in America is generics. The act was to address broadly the marketplace and the way the pharmaceutical industry functioned and behaved."

A U.S. journalist recently paid $45 in South Africa to replace asthma medicine. The same medicine cost only $15 in the United States.

President Mbeki addressed leaders from the African American community in a meeting at the Schomberg Center in Harlem. He said the matter has been "settled." But he also cited one of the biggest problems in South Africa: The economy is still owned by those who owned it under apartheid and little has changed.

This is the context in which the struggle over the pharmaceuticals is taking place.

The U.S. concession represents a major victory for South Africa's people, and therefore for all of southern Africa and its estimated 32 million people who are HIV-positive.

The high death rate from AIDS-related illnesses has dramatically reduced average life expectancy in Zimbabwe from 58 to 39 years. The corn and cotton crops have plummeted to less than 50 percent of previous production due to the AIDS epidemic's impact on the work force.

There are many more victories needed. The drug industry must open the doors to all medications, from those treating tuberculosis to antibiotics, and all the treatments for infections and diseases that become more common and deadly in the world of HIV.

How this infection is handled in Africa may well determine the fate of other oppressed people, from South Asia, Asia, and Latin America, to here at home in the United States, where many poor communities are ill-equipped to handle it.

"Those people in the United States who are protesting against these pharmaceutical companies are engaged in one of the most noble struggles to save humanity," said South African Communist Party General Secretary Blade Nzimande. "No one should be left off the hook so far as this is concerned."

This article is copyright under a Creative Commons License.
Workers World, 55 W. 17 St., NY, NY 10011
Email: ww@workers.org
Subscribe wwnews-subscribe@workersworld.net
Support independent news http://www.workers.org/orders/donate.php)

HOME :: U.S. NEWS :: WORLD NEWS :: EDITORIALS :: SUBSCRIBE :: DONATE